study_id,year,design,effect_type,effect_point,ci_low,ci_high,n_treat,n_ctrl,risk_of_bias,doi,journal_id,outcome,population,adverse_events,duration_weeks
MUSC-GEN-0743_01,2016,randomized controlled trial,SMD,0.3177,0.1783,0.4571,82,64,mixed,10.1234/leucine-musc-gen-0743-01,musculoskeletal_journal,recovery,Adults with recovery concerns,None reported,10
MUSC-GEN-0743_02,2017,randomized controlled trial,SMD,0.3205,0.1755,0.4655,70,67,mixed,10.1234/leucine-musc-gen-0743-02,musculoskeletal_journal,recovery,Adults with recovery concerns,Mild GI discomfort,10
MUSC-GEN-0743_03,2018,randomized controlled trial,SMD,0.3349,0.2001,0.4697,61,74,low,10.1234/leucine-musc-gen-0743-03,musculoskeletal_journal,recovery,Adults with recovery concerns,Mild GI discomfort,8
